Baxter (NYSE:BAX) said today that its Evo IQ infusion system won CE Mark clearance and regulatory approval in Australia. The company plans to start the launch process for its infusion system in the U.K., Ireland, New Zealand and Australia in the third quarter of this year. Get the full story at our sister site, Drug Delivery […]
Business/Financial News
Wall Street Beat | Earnings Reports | Funding Roundup | Mergers & Acquisitions | Initial Public Offerings | Legal News
TSO3 drops Getinge, lands $20m debt round for Sterizone VP4
TSO3 (TSE:TOS) said today it is dropping a distribution agreement with Getinge and that it inked a $20 million debt financing deal with a fund under advisement by Courage Capital Management to support commercialization of its Sterizone VP4 sterilizer. The company’s Sterizone VP4 is a low-temperature sterilization system which uses dual-sterilants of vaporized hydrogen peroxide and ozone […]
Hologic CFO McMahon jumps ship to Agilent | Personnel Moves – August 1, 2018
Hologic (NSDQ:HOLX) said yesterday that its CFO Bob McMahon is leaving to take up a CFO role at Agilent Technologies. The Marlborough, Mass.-based company said that its current chief accounting officer Karleen Oberton has been lifted to CFO, effective today. “Bob has made tremendous contributions to Hologic over the last four years, and we wish him […]
Brazos Medical needs $2m to get Auracis migraine device to market
American Diversified Holdings’ Brazos Biomedical needs $2 million to take its Auracis Tens migraine therapy system to the market, according to a recently released press release from the company. Houston-based Brazos said that its management met with medtech engineering firms and determined that a $2 million budget would float the device through from prototyping to production over […]
Intersect ENT shares tumble on Q2 results
Shares in Intersect ENT (NSDQ:XENT) fell today after the medical device maker missed sales expectations on Wall Street with its second-quarter financial results. The Menlo Park, Calif.-based company posted a net loss of -$4.2 million on sales of $26.3 million for the 3 months ended June 30, for sales growth of 9.7% compared with the same period […]
Aerie expands drug-delivery tech deal with DSM Biomedical
Aerie Pharmaceuticals (NSDQ:AERI) said today that it expanded its drug-delivery R&D deal with DSM Biomedical. The two companies first joined forces in July last year to evaluate the sustained delivery of certain Aerie drugs using DSM’s polymer technology. Initially, the group was focused on developing drug-delivery tech for people with wet age-related macular degeneration and diabetic macular […]
Hologic drops $85m on Faxitron Bioptics
Hologic (NSDQ:HOLX) said yesterday that it dropped $85 million on Faxitron Bioptics and its line of breast health offerings. Tucson, Ariz.-based Faxitron, which makes digital specimen radiography, breast lesion localization and sentinel lymph node biopsy products, posted sales of roughly $27 million during its last fiscal year. “Faxitron, like Hologic, has built a strong brand focused on improving the […]
Valeritas launches V-Go insulin delivery device in New Zealand
Valeritas (NSDQ:VLRX) said today that its V-Go wearable insulin delivery device is now available in New Zealand thanks to an exclusive distribution deal with NZMS Diabetes. According to the terms of the agreement, Valeritas will be responsible for product development, regulatory approval, manufacturing and quality management while NZMS Diabetes will take over the sales, marketing, customer […]
LivaNova beats Q2 expectations
LivaNova (NSDQ:LIVN) handily topped the consensus forecast for its second-quarter results despite a huge bottom-line slide. Formed by the $2.7 billion merger of Italy’s Sorin and Cyberonics in October 2015, in April the company closed the $190 million sale of its cardiac rhythm management business to China’s MicroPort Scientific (HK:00853) and paid $250 million to acquire TandemLife and its cardiopulmonary temporary support […]
NuVasive posts street-beating Q2
Updated to correct revenues to $281.6 million and indicate that the company beat Wall Street expectations for sales. Shares in NuVasive (NSDQ:NUVA) have stayed stable in after-hours trading after the medical device maker beat earnings per share expectations but missed sales consensus on Wall Street with its second quarter earnings. The San Diego-based company posted profits […]
Hologic posts beat-and-raise Q3
Shares in Hologic (NSDQ:HOLX) have stayed steady in after-hours trading after the medical device maker beat expectations on Wall Street with its third quarter fiscal year 2018 earnings. The Marlborough, Mass.-based company posted profits of $112.9 million, or 41¢ per share, on sales of $824 million for the three months ended June 30, seeing 89.7% growth […]